SOHO announces exclusive MDS, AML session on September 8 in Houston; register now
SOHO will hold an exclusive session titled, “Practical Strategies for Optimizing Outcomes in MDS and AML,” starting at 3 pm on Tuesday, September
SOHO will hold an exclusive session titled, “Practical Strategies for Optimizing Outcomes in MDS and AML,” starting at 3 pm on Tuesday, September
The researchers added that early indications from their translational substudies suggest that PET radiomics and immune gene analyses provide promise as biomarkers for
Don’t miss the SOHO 2026 poster walks taking place from Wednesday to Friday during the SOHO 2026 Annual Meeting. More information at soho.click/2026.
When multiple myeloma and chronic lymphocytic leukemia appear in the same patient, they do not derive from the same B-cell but rather develop
The US Food and Drug Administration has approved the checkpoint inhibitor nivolumab (Opdivo) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) for adult
The chimeric antigen receptor T-cell therapy zamtocabtagene autoleucel (zamto-cel) showed encouraging activity and a favorable safety profile in patients with relapsed or refractory
Andrew Lane, MD, PhD, of Dana Farber Cancer Institute, reports the results from a phase 2 trial in tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet
The future of registries in the UK came into focus during an afternoon session at SOHO UK with Priyanka Mehta, MBBS, MD, FRCP,
During the HLH portion of the How I Treat or Manage session at 9.00-9.20 on 4 March, Dr. Gohil will discuss how the
Prof. Amanda Goodall, director of the Executive Master's in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership